Sonova Holding (OTCMKTS:SONVY) Given Consensus Rating of “Reduce” by Brokerages

Sonova Holding (OTCMKTS:SONVY) has received a consensus recommendation of “Reduce” from the eight analysts that are currently covering the company, Marketbeat reports. Four analysts have rated the stock with a sell rating and four have given a hold rating to the company.

A number of equities research analysts have recently issued reports on the stock. Hsbc Global Res cut shares of Sonova from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, May 21st. Kepler Capital Markets upgraded Sonova from a “strong sell” rating to a “hold” rating in a report on Friday, June 6th. Barclays lowered Sonova from a “hold” rating to a “strong sell” rating in a research note on Friday, June 20th. BNP Paribas lowered Sonova from a “strong-buy” rating to a “strong sell” rating in a research report on Wednesday, June 11th. Finally, HSBC downgraded Sonova from a “buy” rating to a “hold” rating in a research report on Wednesday, May 21st.

Sonova Price Performance

Shares of SONVY opened at $57.22 on Friday. Sonova has a 1-year low of $52.83 and a 1-year high of $77.56. The company has a quick ratio of 0.96, a current ratio of 1.27 and a debt-to-equity ratio of 0.45. The firm’s 50 day simple moving average is $61.75 and its 200 day simple moving average is $62.56.

Sonova Increases Dividend

The company also recently declared a dividend, which was paid on Wednesday, July 2nd. Investors of record on Tuesday, June 17th were paid a $0.6243 dividend. This is a boost from Sonova’s previous dividend of $0.57. The ex-dividend date was Monday, June 16th. This represents a yield of 0.99%.

Sonova Company Profile

Sonova Holding AG manufactures and sells hearing care solutions for adults and children in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The Hearing Instruments segments engages in the design, development, manufacture, distribution, and service of hearing instruments and related products, as well as wireless headsets, speech-enhanced hearables, and audiophile headphones under the Phonak, Unitron, Hansaton, and Sennheiser brand names; and audiological care services under the AudioNova, Audium, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton Hearing brands.